Results can be thrust from bench to bedside, but there is also much to be learned by pushing the other way. Heidi Ledford tells tales of clinical trials that have prompted a change in tack.
... London, lead author of "Justice in Translation: From Bench to Bedside in the Developing World" and director of Carnegie Mellon's Center for the Advancement of Applied Ethics and Political ...
... use in patients. This means they can move a lot faster from bench to bedside than newly discovered drugs that often take up to 15 years before they can be applied in patients ...
... of Alzheimer's disease (AD). Unfortunately, the gap between bench and bedside remains as vast as ever. Recent progress, however, has resulted in the development of novel, and in some cases ...
... scarring itself. The researchers applied a true bench-to-bedside approach for this study. Starting with basic research findings from in vitro cell and experimental animal ...
... therapies demonstrates the successful translation of research from bench to bedside, the author note. But they add that this study documents the rapid uptake of newer and more expensive drugs ...
... and the mother of a child with HGPS. In addition to describing this bench-to-bedside story, the ASCB special symposium will spotlight new research suggesting that the basic cellular ...
... of these receptors." Belcher said these results demonstrate the importance of "bench to bedside" discoveries. "We started in tumor cells and then moved to animal models of MD and found that we could stop ...
(PhysOrg.com) -- A new drug developed at the University of California, Davis, to treat diabetes, hypertension and inflammatory diseases has entered Phase IIa of human clinical trials to evaluate its ...
The Annual Meeting of the American Association for Cancer Research remains the premier destination to showcase the newest and most exciting developments in cancer prevention and treatment. At the ...
... . These clinical studies are the latest steps in a multiyear bench-to-bedside project that began with tests of the green tea extract on cancer cells in the laboratory of Mayo ...
... development process and help companies execute the bench-to-bedside process of product development more effectively, researchers at Stanford University have published the first comprehensive ...
... known as the Marshall Protocol as quickly as possible from bench to bedside. Data from the initial ARF trial has been presented at conferences around the world from Karolinska, Sweden ...
... another hurdle in moving this research closer from bench to bedside by successfully identifying a compound that could be administered systemically to achieve the same benefit. Previously, the team ...
... in an oral presentation entitled "TH-302: Bench to bedside with a tumor-selective hypoxia-activated prodrug for lung cancer." Clinical trial patients ...
